DRIO
Income statement / Annual
Last year (2024), DarioHealth Corp.'s total revenue was $27.04 M,
an increase of 32.86% from the previous year.
In 2024, DarioHealth Corp.'s net income was -$42.75 M.
See DarioHealth Corp.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$27.04 M |
$20.35 M |
$27.66 M |
$20.51 M |
$7.58 M |
$7.56 M |
$7.39 M |
$5.17 M |
$2.80 M |
$823.00 K |
| Cost of Revenue |
$13.77 M
|
$14.37 M
|
$18.00 M
|
$16.55 M
|
$5.06 M
|
$4.96 M
|
$5.63 M
|
$3.86 M
|
$3.36 M
|
$1.68 M
|
| Gross Profit |
$13.27 M
|
$5.98 M
|
$9.66 M
|
$3.96 M
|
$2.51 M
|
$2.60 M
|
$1.77 M
|
$1.31 M
|
-$561.00 K
|
-$855.00 K
|
| Gross Profit Ratio |
0.49
|
0.29
|
0.35
|
0.19
|
0.33
|
0.34
|
0.24
|
0.25
|
-0.2
|
-1.04
|
| Research and Development Expenses |
$24.18 M
|
$20.25 M
|
$19.65 M
|
$17.22 M
|
$4.43 M
|
$3.69 M
|
$3.68 M
|
$3.30 M
|
$2.15 M
|
$2.57 M
|
| General & Administrative Expenses |
$20.48 M
|
$18.01 M
|
$16.49 M
|
$23.53 M
|
$12.76 M
|
$5.48 M
|
$5.47 M
|
$4.73 M
|
$3.38 M
|
$2.95 M
|
| Selling & Marketing Expenses |
$26.35 M
|
$23.79 M
|
$30.32 M
|
$39.71 M
|
$15.23 M
|
$11.13 M
|
$10.31 M
|
$7.71 M
|
$4.74 M
|
$1.33 M
|
| Selling, General & Administrative Expenses |
$46.83 M
|
$41.80 M
|
$46.82 M
|
$63.24 M
|
$27.98 M
|
$16.61 M
|
$15.78 M
|
$12.43 M
|
$8.12 M
|
$4.28 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$71.01 M
|
$62.17 M
|
$66.47 M
|
$80.46 M
|
$32.42 M
|
$20.30 M
|
$19.45 M
|
$15.73 M
|
$10.27 M
|
$6.84 M
|
| Cost And Expenses |
$84.78 M
|
$76.41 M
|
$84.47 M
|
$97.01 M
|
$37.48 M
|
$25.26 M
|
$25.08 M
|
$19.59 M
|
$13.64 M
|
$8.52 M
|
| Interest Income |
$1.12 M
|
$1.87 M
|
$506.00 K
|
$44.00 K
|
$61.00 K
|
$16.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$0.00
|
$645.00 K
|
$1.88 M
|
$84.00 K
|
$49.00 K
|
$27.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$7.43 M
|
$4.99 M
|
$3.80 M
|
$3.53 M
|
$457.00 K
|
$551.00 K
|
$207.00 K
|
$195.00 K
|
$387.00 K
|
$335.00 K
|
| EBITDA |
-$50.32 M |
-$54.38 M |
-$56.81 M |
-$73.12 M |
-$29.71 M |
-$17.52 M |
-$17.48 M |
-$14.22 M |
-$10.45 M |
-$7.36 M |
| EBITDA Ratio |
-1.86
|
-2.67
|
-2.05
|
-3.56
|
-3.92
|
-2.32
|
-2.36
|
-2.75
|
-3.73
|
-8.95
|
| Operating Income Ratio |
-2.14
|
-2.76
|
-2.05
|
-3.73
|
-3.95
|
-2.34
|
-2.39
|
-2.79
|
-3.96
|
-9.35
|
| Total Other Income/Expenses Net |
$98.73 M
|
-$3.17 M
|
-$5.38 M
|
-$235.00 K
|
$458.00 K
|
-$31.00 K
|
-$115.00 K
|
-$1.32 M
|
$214.00 K
|
$556.00 K
|
| Income Before Tax |
-$44.60 M
|
-$59.36 M
|
-$62.19 M
|
-$76.73 M
|
-$29.45 M
|
-$17.74 M
|
-$17.80 M
|
-$15.74 M
|
-$10.89 M
|
-$7.14 M
|
| Income Before Tax Ratio |
-1.65
|
-2.92
|
-2.25
|
-3.74
|
-3.89
|
-2.35
|
-2.41
|
-3.05
|
-3.88
|
-8.68
|
| Income Tax Expense |
-$1.85 M
|
$64.00 K
|
$4.00 K
|
$32.00 K
|
-$458.00 K
|
$31.00 K
|
-$115.00 K
|
$1.32 M
|
$55.00 K
|
-$556.00 K
|
| Net Income |
-$42.75 M
|
-$59.43 M
|
-$62.19 M
|
-$76.76 M
|
-$28.99 M
|
-$17.77 M
|
-$17.80 M
|
-$15.74 M
|
-$10.89 M
|
-$7.14 M
|
| Net Income Ratio |
-1.58
|
-2.92
|
-2.25
|
-3.74
|
-3.83
|
-2.35
|
-2.41
|
-3.05
|
-3.88
|
-8.68
|
| EPS |
-0.61 |
-1.93 |
-2.63 |
-4.63 |
-4.86 |
-7.84 |
-15.21 |
-32.7 |
-41.85 |
-75.27 |
| EPS Diluted |
-0.61 |
-1.93 |
-2.63 |
-4.63 |
-4.86 |
-7.84 |
-15.21 |
-32.7 |
-41.85 |
-75.27 |
| Weighted Average Shares Out |
$67.18 M
|
$28.37 M
|
$23.64 M
|
$16.59 M
|
$5.96 M
|
$2.27 M
|
$1.17 M
|
$481.41 K
|
$260.15 K
|
$94.89 K
|
| Weighted Average Shares Out Diluted |
$67.18 M
|
$28.37 M
|
$23.64 M
|
$16.59 M
|
$5.96 M
|
$2.27 M
|
$1.17 M
|
$481.41 K
|
$260.15 K
|
$94.89 K
|
| Link |
|
|
|
|
|
|
|
|
|
|
